Get ready to answer back to your medicine. Swiss drug makers Novartis AG plan to seek regulatory approval in Europe in the next 18 months for a tablet that contains an embedded microchip. The ingestible chip would be activated by stomach acid and send…

Continued here:
New Pill Developed With Microchip

The company joins a growing list of pharmaceutical companies that have been accused by federal prosecutors of illegally promoting drugs for off-label purposes.

Read more from the original source:
Novartis Pays $422.5 Million in Settlement